E-ISSN: 2349-9036 | Peer-Reviewed Journal (Refereed Journal) | Hybrid Open Access
Research & Reviews: A Journal of Drug Design & Discovery [2349-9036(e)]Â is a peer-reviewed hybrid open access journal launched in 2014 covers the latest research on how drugs work, rational approaches such as Structure-based drug design, …
rrjoddd maintains an Editorial Board of practicing researchers from around the world, to ensure manuscripts are handled by editors who are experts in the field of study.
Dr. Sidhartha Sankar Kar, Professor & HOD
School of Pharmacy, DRIEMS University, Cuttack, Odisha, India, 754022
Email :
Institutional Profile Link: https://www.driems.ac.in/faculty/school-of-pharmacy-faculty/dr-sidhartha-sankar-kar-2/
Journal: Research & Reviews: A Journal of Drug Design & Discovery
The process of finding new leads for medicines using natural products is challenging. It discusses bioactive composites generated from natural resources, including phytochemical analysis, characterization, and pharmacological investigation.
Multidrug-resistant TB is a growing worldwide health concern, particularly in high-burden areas. Resistance to frontline drugs like isoniazid and rifampicin is caused by mutations in key Mycobacterium tuberculosis proteins.
The integration of nanomedicine and tissue engineering offers transformative strategies for cancer therapy by directly modulating the physiological processes within the tumor microenvironment (TME).
A complicated, multidisciplinary, and resource-intensive process, the discovery and development of new pharmacological drugs is essential to the advancement of contemporary medicine.
The main issue that the researchers are dealing with is targeted medication delivery to locations. Crosslinking polymers produce nanosponges, which are three-dimensional drug delivery systems at the nanoscale.
Microneedles represent a groundbreaking innovation in drug delivery systems, offering a transformative alternative to conventional hypodermic needles and transdermal patches.
